Published in Br J Dermatol on March 01, 2005
Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol (2013) 2.74
NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol (2013) 1.63
Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol (2015) 1.59
Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J Invest Dermatol (2012) 1.56
Giant congenital melanocytic nevus. An Bras Dermatol (2014) 1.32
Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI. Acta Neuropathol (2012) 0.93
Neurocutaneous melanosis and the Dandy-Walker complex: an uncommon but not so insignificant association. Childs Nerv Syst (2009) 0.88
The etiology and molecular genetics of human pigmentation disorders. Wiley Interdiscip Rev Dev Biol (2012) 0.87
Prevention of malignant melanoma. Hippokratia (2008) 0.78
Congenital melanocytic nevi with primary cerebral melanoma: a rarity. APSP J Case Rep (2013) 0.75
Rapidly lethal metastatic melanoma arising from a large congenital melanocytic naevus. BMJ Case Rep (2009) 0.75
Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients. Dermatopathology (Basel) (2014) 0.75
Intramedullary and retroperitoneal melanocytic tumor associated with congenital blue nevus and nevus flammeus: an uncommon combination of neurocutaneous melanosis and phacomatosis pigmentovascularis--case report. Neurol Med Chir (Tokyo) (2013) 0.75
Giant congenital melanocytic nevi and neurocutaneous melanosis. Case Rep Med (2015) 0.75
A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma. An Bras Dermatol (2017) 0.75
Neurocutaneous melanosis is associated with tethered spinal cord. Childs Nerv Syst (2014) 0.75
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
A note on competing risks in survival data analysis. Br J Cancer (2004) 5.60
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
Leptomeningeal metastases in the MRI era. Neurology (2010) 3.48
Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res (1983) 3.35
Prevalence of incidental Bochdalek's hernia in a large adult population. AJR Am J Roentgenol (2001) 3.24
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol (2001) 3.06
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med (1995) 2.80
Folate and chemoprevention of colorectal cancer: Is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells? Nutrition (2001) 2.75
Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin (1985) 2.57
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst (1998) 2.39
Dermoscopic semiology: further insights into vascular features by screening a large spectrum of nontumoral skin lesions. Br J Dermatol (2004) 2.38
Sequence and organization of genes encoding the human 27 kDa heat shock protein. Nucleic Acids Res (1986) 2.34
Personal exercise habits and counseling practices of primary care physicians: a national survey. Clin J Sport Med (2000) 2.31
Analysis of histone gene expression during the cell cycle in HeLa cells by using cloned human histone genes. Proc Natl Acad Sci U S A (1982) 2.28
Ultraviolet A and melanoma: a review. J Am Acad Dermatol (2001) 2.27
Noninvasive genomic detection of melanoma. Br J Dermatol (2011) 2.17
Laryngeal transplantation and 40-month follow-up. N Engl J Med (2001) 2.12
Organization of human histone genes. Proc Natl Acad Sci U S A (1982) 2.10
Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol (1990) 2.10
Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol (1969) 2.06
Protein-DNA interactions in vivo upstream of a cell cycle-regulated human H4 histone gene. Science (1987) 1.97
Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol (1992) 1.94
Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91
Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol (2000) 1.88
Inhibition of DNA replication coordinately reduces cellular levels of core and H1 histone mRNAs: requirement for protein synthesis. Biochemistry (1984) 1.88
Reassessment of histone gene expression during cell cycle in human cells by using homologous H4 histone cDNA. Proc Natl Acad Sci U S A (1979) 1.87
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol (1991) 1.80
Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res (2000) 1.78
Changing motor synergies in chronic stroke. J Neurophysiol (2007) 1.77
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res (2000) 1.75
Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol (1998) 1.74
Solar nevogenesis: a surrogate for predicting a rise in incidence of malignant melanoma because of ozone depletion. J Am Acad Dermatol (1993) 1.73
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Regulation of cell cycle stage-specific transcription of histone genes from chromatin by non-histone chromosomal proteins. Nature (1975) 1.68
Stroke in patients with cancer: incidence and etiology. Neurology (2004) 1.65
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
Iron overload following bone marrow transplantation in children: MR findings. Pediatr Radiol (1997) 1.63
Bowenoid papulosis of the genitalia. Arch Dermatol (1979) 1.62
A neuroanatomical hypothesis for panic disorder. Am J Psychiatry (1989) 1.62
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
Contrast sensitivity and coherent motion detection measured at photopic luminance levels in dyslexics and controls. Vision Res (1995) 1.60
Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol (1998) 1.60
Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology (2000) 1.59
Influence of physical exercise on polyamine synthesis in the rat skeletal muscle. Eur J Clin Invest (2000) 1.59
A major human histone gene cluster on the long arm of chromosome 1. Science (1984) 1.59
Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics (2000) 1.56
Changes in DNA base sequence induced by gamma-ray mutagenesis of lambda phage and prophage. Genetics (1988) 1.56
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Cutaneous horns. A clinical and histopathologic study. Acta Derm Venereol (1968) 1.55
Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer (1974) 1.55
Nursing shortages and international nurse migration. Int Nurs Rev (2005) 1.53
Malignant melanoma: a review. J Dermatol Surg Oncol (1977) 1.52
Structure and in vitro transcription of a human H4 histone gene. Nucleic Acids Res (1983) 1.51
The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol (1996) 1.48
Effect of monocular occlusion on visuomotor perception and reading in dyslexic children. Lancet (1985) 1.48
Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns. Br J Dermatol (2014) 1.48
Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol (2015) 1.47
Involvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replication. Proc Natl Acad Sci U S A (1986) 1.47
Primary care physicians' views on access and health care reform: the situation in North Carolina. J Fam Pract (1993) 1.46
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant (2001) 1.45
The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med (1981) 1.45
Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol (1979) 1.45
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Cancer (2000) 1.44
Histology and outcomes of newly detected lung lesions in melanoma patients. Ann Oncol (2011) 1.43
Pupil size and reaction during functional endoscopic sinus surgery (FESS). Clin Otolaryngol Allied Sci (2003) 1.42
[Adult-onset Still's disease. Differential diagnosis in recurrent pharyngitis, fever of unknown original and excessive hyperferritinemia]. Dtsch Med Wochenschr (1999) 1.42
Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys (1997) 1.42
Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr (2000) 1.40
Extended family studies for the identification of allogeneic stem cell transplant donors in Jewish and Arabic patients in Israel. Pediatr Transplant (2005) 1.40
The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry (1995) 1.40
Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology (2001) 1.40
Dermoscopic rainbow pattern in non-Kaposi sarcoma lesions. Br J Dermatol (2009) 1.39
Modulation of epidermal growth factor-induced cell proliferation by an omega-3 fatty-acid-containing lipid emulsion on human pancreatic cancer cell line Mia Paca-2. Nutrition (2001) 1.38
Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol (1990) 1.38
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
[Pathogenesis and treatment of pruritus in patients with cholestasis]. Z Gastroenterol (2003) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology (1995) 1.38
Efficient in vivo microRNA targeting of liver metastasis. Oncogene (2010) 1.36
Evaluation of Elispot assays: influence of method and operator on variability of results. J Immunol Methods (2004) 1.36
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34
Studies on the ecology of Lyme disease in a deer forest in County Galway, Ireland. J Med Entomol (1992) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Roles of the C terminus of Armadillo in Wingless signaling in Drosophila. Genetics (1999) 1.32
Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol (1990) 1.31
A standardization method to adjust for the effect of patient selection in phase II clinical trials. Stat Med (2001) 1.30
Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther (2007) 1.29
Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol (1977) 1.29
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation (1994) 1.27
White shiny structures: dermoscopic features revealed under polarized light. J Eur Acad Dermatol Venereol (2011) 1.27
Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol (1996) 1.27